Breaking News Instant updates and real-time market news.

UAA

Under Armour

$21.94

0.14 (0.64%)

, UA

Under Armour

$19.66

0.19 (0.98%)

06:10
04/18/19
04/18
06:10
04/18/19
06:10

Under Armour Q1 expectations 'at least achievable,' says Piper Jaffray

Piper Jaffray analyst Erinn Murphy says her work year-to-date indicates generally well controlled inventory across the domestic athletic industry. Currently, Under Armour (UAA) online clearance styles are down 19% year-over-year versus Nike's (NKE) down 5% and Adidas' (ADDYY) up 96%. The analyst believes industry competition "should remain rational" during 2019. Further, Q1 consensus expectations for Under Armour are "at least achievable" and management should maintain fiscal 2019 guidance, Murphy tells investors in a pre-earnings research note. The analyst this quarter has seen on-going traction with HOVR's footwear platform, broader focus with Under Armour's women's and a well-supported launch of Rush. She keeps an Overweight rating on Under Armour shares with a $30 price target.

UAA

Under Armour

$21.94

0.14 (0.64%)

UA

Under Armour

$19.66

0.19 (0.98%)

NKE

Nike

$88.74

0.84 (0.96%)

ADDYY

Adidas

$0.00

(0.00%)

  • 09

    May

  • 09

    May

UAA Under Armour
$21.94

0.14 (0.64%)

04/09/19
RILY
04/09/19
NO CHANGE
RILY
Under Armour continues to lag behind competitors, says B. Riley FBR
B. Riley FBR analyst Susan Anderson says her firm's annual athletic footwear/apparel survey showed that Under Armour (UAA) continues to lag behind competitors across basketball, running, and casual footwear and athletic apparel. Respondents placed Under Armour behind brands such as New Balance and Puma, in addition to Nike (NKE) and Adidas (ADDYY), which maintained the number one and two spots in this year's survey, Anderson tells investors in a research note. She keeps a Sell rating on Under Armour with a $12 price target.
04/10/19
SBSH
04/10/19
UPGRADE
Target $29
SBSH
Buy
Under Armour assumed with a Buy from Neutral at Citi
Citi analyst Paul Lejuez assumed coverage of Under Armour (UAA) from Kate McShane and upgraded the shares to Buy from Neutral. He raised his price target for the stock to $29 from $23. Under Armour is "growing up" with a renewed focus on driving profitability and return on invested capital, Lejuez tells investors in a research note. With just a 3.4% EBIT margin in 2018, the company has the opportunity to recapture 600 basis points in EBIT margin over the next several years, says the analyst. And near-term, Lejuez sees upside to management's fiscal 2019 gross margin guidance.
04/10/19
04/10/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. First Solar (FSLR) upgraded to Conviction Buy from Buy at Goldman Sachs with analyst Brian Lee citing his view on two potential company-specific catalysts. 2. Disney (DIS) upgraded to Outperform from Market Perform at BMO Capital with analyst Daniel Salmon saying with tomorrow's investor day, two Star Wars-themed lands opening in the domestic parks this summer, the launch of streaming service Disney+ before year-end, and a potential re-start of the buyback program within 12 months, Disney shares now have catalysts to go along with downside protection. 3. Under Armour (UA, UAA) assumed with a Buy from Neutral at Citi with analyst Paul Lejuez saying Under Armour is "growing up" with a renewed focus on driving profitability and return on invested capital. 4. KB Home (KBH) upgraded to Neutral from Underweight at JPMorgan with analyst Michael Rehaut saying the ongoing shift towards smaller-sized first-time product and double-digit community count growth should drive "above average fundamentals" in fiscal 2019 for KB Home. 5. Nordstrom (JWN) upgraded to Overweight from Sector Weight at KeyBanc with analyst Edward Yruma saying recent meetings with co-CEO Erik Nordstrom and CFO Anne Bramman affirm that the company is prepared to transition its asset base as e-commerce continues to grow. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
04/12/19
JEFF
04/12/19
NO CHANGE
JEFF
Under Armour discounts flat to down for 12th straight month, says Jefferies
Jefferies analyst Randal Konik says his firm's March webscrapes illustrate that Under Armour's (UAA) percentage of product on discount is flat to down for the twelfth month in a row year-over-year, Jefferies analyst Randal Konik tells investors in a research note. Further, the webscrapes show Adidas's (ADDYY) percentage of product on discount is up for the twelfth month in a row year-over-year, adds the analyst. In addition, visits to Finish Line (FINL), Foot Locker (FL), and Under Armour websites reveal the HOVR, Project Rock, and Curry 6 are sold out in several sizes, indicating strong demand, says Konik. He believes Nike (NKE) continues to dominate Adidas in running in the U.S., with strength in Air VaporMax and Air Max 270. The analyst also thinks the data bodes well for Under Armour's's sales and margins in Q1.
UA Under Armour
$19.66

0.19 (0.98%)

NKE Nike
$88.74

0.84 (0.96%)

04/10/19
SBSH
04/10/19
INITIATION
Target $100
SBSH
Buy
Nike assumed with a Buy rating, $100 price target at Citi
Citi analyst Paul Lejuez assumed coverage of Nike from Kate McShane and kept a Buy rating on the shares. He raised his price target for the stock to $100 from $96. Nike is the dominant player in the global athletic footwear and apparel market, which is a "healthy and growing market buoyed by structural tailwinds," Lejuez tells investors in a research note.
04/10/19
SBSH
04/10/19
DOWNGRADE
Target $68
SBSH
Neutral
Foot Locker assumed with a Neutral from Buy at Citi
Citi analyst Paul Lejuez assumed coverage of Foot Locker (FL) from Kate McShane and downgraded the shares to Neutral from Buy. He also lowered his price target for the stock to $68 from $72. While Foot Locker has "tailwinds at its back" in North America with comps inflecting positively in Q4, the company still faces many of the same headwinds as other specialty retailers given its "significant" mall exposure and EBIT pressure from direct-to-consumer, Lejuez tells investors in a research note. He believes Nike's direct-to-consumer ambitions are a "secular headwind" for Foot Locker.
ADDYY Adidas
$0.00

(0.00%)

02/25/19
02/25/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Norwegian Cruise Line (NCLH) upgraded to Outperform from Neutral at Macquarie. 2. Brunswick (BC) upgraded to Overweight from Neutral at JPMorgan by analyst Steven Zaccone, who said that following recent "encouraging" data points on the marine industry, macro backdrop, and company-specific growth drivers, the setup is more favorable to own Brunswick in 2019. 3. UGI Corporation (UGI) upgraded to Buy from Neutral at UBS by analyst Shneur Gershuni, who said the 8% selloff since mid-December is an overreaction to the company's recent Q1 miss on the back of warm weather. The analyst believes UGI's strategic review of AmeriGas (APU) could "substantially increase" the company's cash flow and market capitalization if a roll-up is the outcome.4. Infinera (INFN) upgraded to Neutral from Sell at MKM Partners by analyst Michael Genovese, who said the company's commentary about new bookings was better than he expected. Genovese also noted that management's view of significant backlog growth in Q4 and expectations for another increase in Q1, but warned that there is still "significant risk" to Infinera's 2019 revenue outlook being a "high hurdle." 5. Adidas (ADDYY) upgraded to Outperform from Market Perform at Wells Fargo by analyst Tom Nikic, who said his math suggests a greater-than-expected contribution from the long-awaited democratization of the Yeezy sub-brand. The company seems to have hit a ''lull'' on new product launches for the core brand and faces headwinds from the 2018 World Cup through Q2 of 2019, but Nikic believes these challenges are well understood by investors, and the ''opening the faucet'' on the Yeezy brand can get Adidas through these 2019 challenges and allow for a ''soft landing'' on the top line in 2019. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/14/19
MSCO
03/14/19
NO CHANGE
Target $103
MSCO
Overweight
Morgan Stanley sees Q3 EPS beat coming from Nike
Morgan Stanley analyst Lauren Cassel previewed Nike's (NKE) Q3 report, stating that she expects an EPS beat and a high-single digit constant currency revenue growth forecast for FY20 coming from the company. Adidas' (ADDYY) Q4 sales ex-Reebok were notably softer in North America on a constant currency basis, noted Cassel, who reads this as a sign that its share losses are accelerating. She maintains an Overweight rating and $103 price target on Nike ahead of the company's Q3 earnings report on Thursday, March 21.

TODAY'S FREE FLY STORIES

GE

General Electric

$10.04

-0.2 (-1.95%)

21:05
06/17/19
06/17
21:05
06/17/19
21:05
Periodicals
General Electric to cut another 450 jobs in Switzerland, Reuters says »

General Electric will lay…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AJG

Arthur J. Gallagher

$86.25

-1.52 (-1.73%)

20:00
06/17/19
06/17
20:00
06/17/19
20:00
Hot Stocks
Arthur J. Gallagher acquires P2 Group, terms not stated »

Arthur J. Gallagher &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 20

    Jun

AGLNF

AGL Energy

$0.00

(0.00%)

19:28
06/17/19
06/17
19:28
06/17/19
19:28
Upgrade
AGL Energy rating change at Macquarie »

AGL Energy upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPWR

SunPower

$8.27

0.03 (0.36%)

, RUN

Sunrun

$17.09

0.64 (3.89%)

19:02
06/17/19
06/17
19:02
06/17/19
19:02
Upgrade
SunPower, Sunrun, SolarEdge rating change at Goldman Sachs »

SunPower, Sunrun upgraded…

SPWR

SunPower

$8.27

0.03 (0.36%)

RUN

Sunrun

$17.09

0.64 (3.89%)

SEDG

SolarEdge

$56.58

0.09 (0.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MGI

MoneyGram

$1.44

-0.06 (-4.00%)

, PHAS

PhaseBio

$12.25

0.74 (6.43%)

18:48
06/17/19
06/17
18:48
06/17/19
18:48
Hot Stocks
Fly Intel: After Hours Movers »

HIGHER: MoneyGram (MGI)…

MGI

MoneyGram

$1.44

-0.06 (-4.00%)

PHAS

PhaseBio

$12.25

0.74 (6.43%)

SPWR

SunPower

$8.27

0.03 (0.36%)

RUN

Sunrun

$17.09

0.64 (3.89%)

STLD

Steel Dynamics

$26.23

-0.19 (-0.72%)

BHVN

Biohaven Pharmaceutical

$57.33

-5.63 (-8.94%)

RMTI

Rockwell Medical

$4.39

0.2 (4.77%)

CALA

Calithera Biosciences

$5.87

0.64 (12.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 27

    Jun

  • 27

    Jun

  • 18

    Jun

  • 19

    Jun

AAPL

Apple

$193.90

1.06 (0.55%)

18:44
06/17/19
06/17
18:44
06/17/19
18:44
Periodicals
Apple's tvOS 13 beta 2 includes Picture-in-Picture support, 9to5Mac reports »

Apple's tvOS 13 beta…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SEDG

SolarEdge

$56.58

0.09 (0.16%)

18:33
06/17/19
06/17
18:33
06/17/19
18:33
Upgrade
SolarEdge rating change at Goldman Sachs »

SolarEdge upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RUN

Sunrun

$17.09

0.64 (3.89%)

18:33
06/17/19
06/17
18:33
06/17/19
18:33
Upgrade
Sunrun rating change at Goldman Sachs »

Sunrun upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPWR

SunPower

$8.27

0.03 (0.36%)

18:33
06/17/19
06/17
18:33
06/17/19
18:33
Upgrade
SunPower rating change at Goldman Sachs »

SunPower upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BLSFY

Bluescope Steel

$0.00

(0.00%)

18:32
06/17/19
06/17
18:32
06/17/19
18:32
Hot Stocks
Bluescope Steel cuts FY19 EBIT growth view to up 6% from up 10% »

BlueScope announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IFF

International Flavors

$147.54

-1.25 (-0.84%)

18:24
06/17/19
06/17
18:24
06/17/19
18:24
Hot Stocks
International Flavors CEO: We have planned for Brexit and China is benign for us »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VZ

Verizon

$57.63

-0.65 (-1.12%)

18:24
06/17/19
06/17
18:24
06/17/19
18:24
Periodicals
Senator aims to bar Huawei from seeking damages in patent courts, Reuters says »

U.S. Senator Marco Rubio…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jun

  • 20

    Jun

  • 26

    Jun

  • 27

    Jun

  • 09

    Jul

  • 01

    Aug

BHVN

Biohaven Pharmaceutical

$57.33

-5.63 (-8.94%)

18:12
06/17/19
06/17
18:12
06/17/19
18:12
Hot Stocks
Breaking Hot Stocks news story on Biohaven Pharmaceutical »

Biohaven Pharmaceutical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DISH

Dish

$39.00

1.46 (3.89%)

18:04
06/17/19
06/17
18:04
06/17/19
18:04
Hot Stocks
Dish launches OnTech Smart Services »

Dish announced the launch…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

T

AT&T

$32.30

-0.06 (-0.19%)

18:03
06/17/19
06/17
18:03
06/17/19
18:03
Hot Stocks
AT&T wins 24 GHz spectrum following FCC Auction 102 »

AT&T is the winning…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

BHVN

Biohaven Pharmaceutical

$57.33

-5.63 (-8.94%)

18:02
06/17/19
06/17
18:02
06/17/19
18:02
Syndicate
Biohaven Pharmaceutical offers to sell $300M in common stock »

Goldman Sachs & Co.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VSM

Versum Materials

$51.42

0.01 (0.02%)

, MKGAY

Merck KGaA

$0.00

(0.00%)

18:01
06/17/19
06/17
18:01
06/17/19
18:01
Hot Stocks
Versum Materials shareholders approve merger with Merck KGaA »

Versum Materials (VSM)…

VSM

Versum Materials

$51.42

0.01 (0.02%)

MKGAY

Merck KGaA

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jun

VLO

Valero

$76.93

0.19 (0.25%)

18:00
06/17/19
06/17
18:00
06/17/19
18:00
Periodicals
Valero restarting Port Arthur, Texas refinery hydrocracker, Reuters says »

Valero is restarting the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

VLO

Valero

$76.93

0.19 (0.25%)

17:59
06/17/19
06/17
17:59
06/17/19
17:59
Periodicals
Valero restarting Meraux, Louisiana refinery hydrocracker, Reuters says »

Valero is restarting the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

MGI

MoneyGram

$1.44

-0.06 (-4.00%)

17:44
06/17/19
06/17
17:44
06/17/19
17:44
Hot Stocks
MoneyGram spikes almost 140% after blockchain company Ripple investment »

Money transfer company…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

JKS

JinkoSolar

$22.59

-2.08 (-8.43%)

17:37
06/17/19
06/17
17:37
06/17/19
17:37
Downgrade
JinkoSolar rating change at UBS »

JinkoSolar downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

FCEL

FuelCell

$0.33

-0.0231 (-6.56%)

17:26
06/17/19
06/17
17:26
06/17/19
17:26
Earnings
FuelCell reports Q2 ($2.06), consensus ($2.24) »

Reports Q2 revenue $9.2M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RMTI

Rockwell Medical

$4.39

0.2 (4.77%)

17:25
06/17/19
06/17
17:25
06/17/19
17:25
Hot Stocks
Breaking Hot Stocks news story on Rockwell Medical »

Rockwell Medical down 21%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jun

VRS

Verso

$17.91

-0.24 (-1.32%)

17:21
06/17/19
06/17
17:21
06/17/19
17:21
Hot Stocks
Verso adopts limited duration stockholder rights plan »

Verso announced that its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CHVKF

China Vanke Co

$0.00

(0.00%)

17:19
06/17/19
06/17
17:19
06/17/19
17:19
Downgrade
China Vanke Co rating change at Morgan Stanley »

China Vanke Co downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.